» Articles » PMID: 36303313

Impact of Cardiovascular Diseases on Mortality in Gastric Cancer Patients with Preexisting Chronic Disease

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2022 Oct 28
PMID 36303313
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Chronic diseases and cardiovascular diseases (CVD) have been independently linked to poorer cancer outcomes. This study investigated whether gastric cancer patients with hypertension, diabetes, or dyslipidemia have higher mortality if diagnosed with CVD in the past year before cancer diagnosis.

Materials And Methods: Data were obtained from the National Health Insurance database for 2002 to 2019. The study population consisted of gastric cancer patients with hypertension, diabetes, or dyslipidemia. The outcome measure was 5-year mortality in relation to incident status of CVD within 1 year before cancer diagnosis. A survival analysis was conducted using the Cox proportional hazards model. Subgroup analysis was conducted according to age, economic status, and type of hospital first visited for cancer treatment.

Results: Of a total of 6458 individuals, 2123 (32.7%) were diagnosed with CVDs in the past year before cancer diagnosis. Compared to participants without a history of CVD, those who were diagnosed with CVD showed a higher risk of 5-year mortality (hazard ratio 1.259, 95% confidence interval 1.138-1.394). The extent to which the mortality risk differed between those with and without CVD was greater for individuals of low economic status and in those receiving their initial cancer treatment in a general hospital.

Conclusion: Patients with gastric cancer and hypertension, diabetes, or dyslipidemia diagnosed with CVD within 1 year before their cancer diagnosis had a higher mortality risk, emphasizing the importance of managing cancer patients with chronic disease and subsequent incidence of CVDs.

Citing Articles

Reviewing the path to balance: mechanisms and management of hypertension associated with targeting vascular endothelium in cancer therapy.

Si F, Ma X, Liu Q, Yu J Hypertens Res. 2025; 48(3):1034-1047.

PMID: 39820066 DOI: 10.1038/s41440-024-02086-8.


The impact of diabetes mellitus on short and long term outcomes in patients with gastric cancer following radical surgery: a retrospective cohort study with propensity score matching.

Yu Z, Liang C, Li R, Xu Q, Gao J, Li P BMC Cancer. 2024; 24(1):1461.

PMID: 39604929 PMC: 11603664. DOI: 10.1186/s12885-024-13232-3.


A 5-Year Mortality Prediction Model for Prostate Cancer Patients Based on the Korean Nationwide Health Insurance Claims Database.

Kim J, Kim Y, Kim Y, Kang H J Pers Med. 2024; 14(10).

PMID: 39452565 PMC: 11509071. DOI: 10.3390/jpm14101058.


Effectiveness of endovascular treatment for in-hospital stroke vs. community-onset stroke: a propensity score-matched analysis.

Jung J, Kim K, Yun J, Nam H, Heo J, Baik M J Neurol. 2024; 271(5):2684-2693.

PMID: 38376545 DOI: 10.1007/s00415-024-12232-4.

References
1.
Kang M, Won Y, Lee J, Jung K, Kim H, Kong H . Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019. Cancer Res Treat. 2022; 54(2):330-344. PMC: 9016309. DOI: 10.4143/crt.2022.128. View

2.
. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2019; 5(1):42-54. PMC: 7033564. DOI: 10.1016/S2468-1253(19)30328-0. View

3.
Yen F, Cheng-Chung Wei J, Chiu L, Hsu C, Hwu C . Diabetes, hypertension, and cardiovascular disease development. J Transl Med. 2022; 20(1):9. PMC: 8722333. DOI: 10.1186/s12967-021-03217-2. View

4.
Tseng L, Tseng Y, Jiang Y, Chang C, Chung C, Lin B . Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009. J Formos Med Assoc. 2012; 111(11):625-36. DOI: 10.1016/j.jfma.2012.09.010. View

5.
Batra A, Sheka D, Kong S, Cheung W . Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer. BMC Cancer. 2020; 20(1):1004. PMC: 7559447. DOI: 10.1186/s12885-020-07487-9. View